Shares of Eli Lilly finished Thursday 3% higher despite an earnings report that showed sales of its blockbuster GLP-1 ...

As more research is published about the health benefits associated with GLP-1s, like sleep apnea, heart disease, and ...

The AP-NORC survey shows about half of U.S. adults believe it is a good thing for adults to use Ozempic, Wegovy and similar ...

When Trump ran for president in 2016, he promised to have Medicare negotiate drug prices ... diabetes and heart disease: Rybelsus, Ozempic and Wegovy. These negotiations would have to be implemented ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

Coverage of obesity drugs in health plans and the rapid adoption of artificial intelligence are two areas of change that health plans will face during the coming year. A panel of Avalere experts ...

When Trump ran for president in 2016, he promised to have Medicare negotiate drug prices ... diabetes and heart disease: ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...